Reports from Icahn School of Medicine at Mount Sinai Provide New Insights into Cancer [Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a Cyp3a4 Substrate, Plus Cyp3a4-interacting Antiretroviral Therapy In People Living With Hiv and ...]

Media coverage

• Title	Reports from Icahn School of Medicine at Mount Sinai Provide New Insights into Cancer [Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a Cyp3a4 Substrate, Plus Cyp3a4-interacting Antiretroviral Therapy In People Living With Hiv and ...]
  Media name/outlet	Clinical Trials Daily
  Country/Territory	United States
  Date	11/03/24
  Persons	Joseph Sparano